TriGemX Bio to go public via merger with TCGX Acquisition, plans Nasdaq listing under TGEM

TriGemX Bio will go public through a merger with TCGX Acquisition Corp. and plans a Nasdaq listing under the ticker TGEM. Upon closing, the combined company is expected to receive roughly $246 million in gross proceeds.

Detected & updated continuously · Source: Nebula